http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-298429-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb3edb9a697ebfa78026d99c5a81b3c3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B05C19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J51-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B05C19-02 |
| filingDate | 1964-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1964-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-298429-A1 |
| titleOfInvention | A METHOD OF PRODUCING MONO AND POLYESTERS OF STRENGTH, ANDRENE AND CORTICOID STEROID HORMONES |
| abstract | A method of producing mono and polyesters of estrogenic, androgenic steroid hormones and corticosteroids selected from the group consisting of estra-1,3,5 (10) -triene-17beta-ol, estra-1,3,5 (10) -triene -3,17beta-diol, estra-1,3,5 (10) -triene-3,17alpha-diol, estra-1,3,5 (10) -triene-3,17beta-diol-16-one, estra -1,3,5 (10) -trieno-3,16beta, 17heta-triol, 17alfa-ethynyl-estra-1,3,5 (10) -trieno-3,17beta-diol, estra-1,3,5 (10) -triene-3,17-bis-diol-3-methyl-ether, estra-1,3,5 (10) -triene-3,17-beta-diol-17-methylether, androstane-3alpha, 17-beta-diol, androstane -3-alpha-ol-17-one, androstane-3beta-ol-17-one, 19-nor-androst-4-ene-17beta-ol-3-one, 17alpha-ethynyl-19-nor-androst-4 -one-17beta-ol-3-one, androst-5-ene-3beta-ol17-one, pregnane-3alpha, 20alpha-diol, etiocholan-3alpha-ol-17-one, prega-5-ene-3beta-ol -20-one, 4-chloro-19-nor-androst-4-ene-17beta-ol-3-one, 1-methyl-androet-l-ene-17beta-ol-3-one, 17 alpha-methyl- androsta-1,4-diene-17alpha-ol-3-one, pregn-4-ene-17alpha, 21-diol-3,11,20-trione, pregn-4-ene-11beta, 17alpha, 2 1-triol-3,20-dione, pregn-4-ene-11beta, 21-diol-3,20-dione, pregn-4-ene-21-ol-3,11,20-trione, pregn-4- eno-21-ol-3,20-dione, pregn-1,4-diene-17alpha, 21-diol-3,11,20-trione, pregna-1,4-diene-11beta, 17alpha, 21-triol- 3,20-dione, 6alpha-methyl-pregna-1,4-diene-11beta, 17alpha, 21-triol-3,20-dione, 9alpha-fluoro-pregn-4-ene-11beta, 17alpha, 21-triol- 3,20-dione, 6 alpha-difluoro-pregn-1,4-diene-11beta, 16alpha, 17alpha, 21-tetrol-3,20-dione and 16alpha-methyl-9alpha-fluoro-pregna-1,4-diene -11 beta, 17alpha-21-triol-3,20-dione with the N-bis- (beta-haloethyl) -carbamic acid of the formula ** (See formula) ** wherein X is selected from the group consisting of chlorine and bromine, characterized in that a carbonyl compound of formula COY2, wherein Y is selected from the group consisting of chlorine and bromine is reacted with one of the following compounds; a) a steroid hormone of those specified above, and b) an N-bis- (betahaloethyl) -amine of the general formula ** (See formula) ** wherein X is as defined above, with the resulting haloformide derivative subsequently being reacted with the other of said compounds to form the desired carbamic acid ester. (Machine-translation by Google Translate, not legally binding) |
| priorityDate | 1963-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.